WHO Survey: 90% of Countries Report Disrupted Essential Health Services

⚠ This alert was published more than 90 days ago.The outbreak situation or advisory level may have changed. Check CDC, WHO, or your government's travel advisories for current information.

What WHO Reported

On 31 August 2020, the World Health Organization published the first indicative results of its Rapid assessment of continuity of essential health services during the COVID-19 pandemic. The survey was circulated to 159 countries across all WHO regions except the Americas, with 105 responses (66% response rate) from senior ministry of health officials covering March–June 2020.

Key findings (public information):

  • Approximately 90% of responding countries reported some disruption to essential health services; low- and middle-income countries reported the greatest difficulty.
  • On average, countries reported disruption in 50% of 25 tracer services.
  • Most frequently disrupted: routine immunization outreach (70%) and facility-based immunization (61%), non-communicable disease diagnosis and treatment (69%), family planning and contraception (68%), mental health treatment (61%), cancer diagnosis and treatment (55%).
  • Also disrupted: malaria diagnosis/treatment (46%), tuberculosis case detection/treatment (42%), antiretroviral treatment (32%).
  • Emergency services were affected in roughly one in four countries: 24-hour emergency rooms (22%), urgent blood transfusion (23%), emergency surgery (19%).
  • Drivers were mixed: 76% cited reduced outpatient attendance (lockdowns, cost, lower demand); 66% cited cancellation of elective services. Staff redeployment, facility closures, and interruptions in supply of medical equipment and health products were also reported.
  • Only 14% of countries reported removing user fees, a WHO-recommended mitigation measure.

WHO announced the COVID-19: Health Services Learning Hub and further sub-national and facility-level surveys to track longer-term impacts.

Relevance for International Travelers

The survey describes health-system capacity, not a disease outbreak. For travelers, the practical signal is that routine, elective, chronic-disease, immunization, and even some emergency and blood-transfusion services may be reduced or rescheduled in destination countries during periods of health-system strain. Pharmaceutical and medical-device supply chains were also reported as affected in some settings.

Pharmacist's note: This is a health-systems monitoring report, not clinical guidance, and nothing here should be read as advice to start, stop, or alter any medicine. From a pharmaceutical-services perspective, the noteworthy items are the reported interruptions in health-product supply chains and the reported changes to prescribing practices in some countries — both of which mean that local availability of a given product, strength, or brand abroad cannot be assumed to mirror availability at home. Travelers with ongoing therapy are generally encouraged to discuss trip planning, supply continuity, documentation of their regimen, and local regulatory requirements with their own prescriber and pharmacist well before departure, and to verify current destination-specific conditions through official sources, as this 2020 snapshot reflects conditions during the early pandemic period and is now historical.

Primary sources

PharmTrip may include promotional content. Products and services are independently evaluated by a licensed pharmacist and rankings are never altered by advertiser requests. Information reflects what was current at the time of writing — please verify the latest terms on each provider's official site.